The use of desk-top cholesterol analysers in general practice.

An examination of the use of desk-top cholesterol analysers was performed within 10 practices in Kirklees, West Yorkshire. The survey entailed a questionnaire survey of the principal users of desk-top cholesterol analysers and the analysis of two laboratory quality control samples. The majority of practices used Boehringer Lipotrend, with frequency of use varying from < 5 tests/week to a maximum of 20/week. Training by manufacturers was absent in four practices. The maintenance of analysers was inadequate in seven practices as was quality control in five practices. Analysis of laboratory quality control samples showed about 50% of results within 0.5 mmol/l of mean, but 20.6% differed from mean by > 1 mmol/l. The coefficients of variation were 18% and 20% respectively. The use of desk-top cholesterol analysers is increasing in general practice, but improvements in training and quality control are necessary to ensure precise and accurate results with near-patient testing.

[1]  H. von Schenck,et al.  Laboratory and field evaluation of three desktop instruments for assay of cholesterol and triglyceride. , 1987, Clinical chemistry.

[2]  S. Havas,et al.  Performance of the Reflotron in Massachusetts' Model System for Blood Cholesterol Screening Program. , 1992, American journal of public health.

[3]  P. Masson,et al.  Improved sample and reagent pipetting with the MINILAB. , 1990, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[4]  B. Leijnse,et al.  Use of the Reflotron system for cholesterol assay in capillary blood, venous blood, and serum--evaluation of accuracy and lot-to-lot reagent comparability. , 1988, Clinical chemistry.

[5]  P. Broughton,et al.  Quality of plasma cholesterol measurements in primary care. , 1989, BMJ.

[6]  L. Dusenbury,et al.  Evaluation of a simple method for measuring blood cholesterol levels using non-laboratory observers. , 1988, The American journal of medicine.

[7]  W. Kannel,et al.  Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. , 2020, Annals of internal medicine.

[8]  K. Schneider,et al.  Reflotron cholesterol measurement evaluated as a screening technique. , 1988, Clinical chemistry.

[9]  P. Fischer,et al.  A clinician's guide to the office measurement of cholesterol. , 1988, JAMA.

[10]  R. Belsey,et al.  Evaluation of a laboratory system intended for use in physicians' offices. II. Reliability of results produced by health care workers without formal or professional laboratory training. , 1987, JAMA.

[11]  P. Broughton,et al.  Improving the quality of plasma cholesterol measurements in primary care. , 1990, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[12]  C. Reid,et al.  Measuring blood cholesterol outside the pathology laboratory: issues of accuracy and reliability. , 2010, Australian journal of public health.